PARP inhibitors and IR join forces to strike glioblastoma-initiating cells

Cell Death and Differentiation

Volumn 21, Issue 2, 2014, Pages 192-193

  Lugli, N ^a,b   Kamileri, I ^b   Halazonetis, T D ^b  

^a National Centre of Competence in Research Frontiers in Genetics   (Switzerland)

^b UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYGUANINE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; OLAPARIB; REACTIVE OXYGEN METABOLITE; SINGLE STRANDED DNA; TEMOZOLOMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;

APOPTOSIS; BREAST EPITHELIUM; CANCER STEM CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; DNA DAMAGE; EDITORIAL; GLIOBLASTOMA; GLIOBLASTOMA INITIATING CELL; HEMATOPOIETIC STEM CELL; HUMAN; IONIZING RADIATION; NEURAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; STEM CELL; TUMOR SUPPRESSOR GENE; ANIMAL; MALE; METABOLISM; PATHOLOGY;

ANIMALS; GLIOBLASTOMA; HUMANS; MALE; NEOPLASTIC STEM CELLS; POLY(ADP-RIBOSE) POLYMERASES;

EID: 84892416027     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2013.172     Document Type: Editorial

References (20)

1. Stupp R et al. Lancet Oncol 2009; 10: 459-466.
2. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J et al. Cancer Res 2003; 63: 5821-5828.
3. Galli R, Binda E, Orfanelli U, Cipelletti B, Gritti A, De Vitis S et al. Cancer Res 2004; 64: 7011-7021.
4. Yuan X, Curtin J, Xiong Y, Liu G, Waschsmann-Hogiu S, Farkas DL et al. Oncogene 2004; 23: 9392-9400.
5. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB et al. Nature 2006; 444: 756-760.
6. Rivera M, Sukhdeo K, Yu J. Front Oncol 2013; 3: 74.
7. Liu G, Yuan X, Zeng Z, Tunici P, Ng H, Abdulkadir IR et al. Mol Cancer 2006; 5: 67.
8. Venere, Hamerlik P, Wu Q, Rasmussen RD, Song LA, Vasanji A et al. Cell Death Differ 2014; 21: 258-269.
9. Bertram C, Hass R. Biol Chem 2008; 389: 211-220.
10. Davar D, Beumer JH, Hamieh L, Tawbi H. Curr Med Chem 2012; 19: 3907-3921.
11. Ito K, Hirao A, Arai F, Matsuoka S, Takubo K, Hamaguchi I et al. Nature 2004; 431: 997-1002.
12. Diehn M, Cho RW, Lobo NA, Kalisky T, Dorie MJ, Kulp AN et al. Nature 2009; 458: 780-783.
13. Smith J, Ladi E, Mayer-Proschel M, Noble M. Proc Natl Acad Sci USA 2000; 97: 10032-10037.
14. Tsatmali M, Walcott EC, Crossin KL. Brain Res 2005; 1040: 137-150.
15. Tsatmali M, Walcott EC, Makarenkova H, Crossin KL. Mol Cell Neurosci 2006; 33: 345-357.
16. Le Belle JE, Orozco NM, Paucar AA, Saxe JP, Mottahedeh J, Pyle AD et al. Cell Stem Cell 2011; 8: 59-71.
17. Bryant HE, Schultz N, Thomas HD, Parker KM, Flower D, Lopez E et al. Nature 2005; 434: 913-917.
18. Farmer H, McCabe N, Lord CJ, Tutt AN, Johnson DA, Richardson TB et al. Nature 2005; 434: 917-921.
19. Helleday T. Mol Oncol 2011; 5: 387-393.
20. Garber K. Nat Rev Drug Discov 2013; 12: 725-727.